Abstract
Background: Primary research on hemorrhagic Moyamoya disease (MMD) often focuses on rebleeding and clinical prognosis, with limited emphasis on postoperative collateral formation and cerebral hemodynamics. Objective: This study compares the effects of combined (CB) and indirect (IB) bypass revascularization on these physiological and clinical outcomes. Methods: 37 hemorrhagic MMD patients (68 hemispheres) were retrospectively analyzed, comparing CB (direct + indirect) and IB (indirect only) procedures. Results: CB demonstrated significantly lower recurrent stroke events, better functional outcomes (mRS ≤ 2), and superior neovascularization and hemodynamic improvement (rCBF) compared to IB. Conclusion: Combined bypass offers superior postoperative collateral formation, cerebral hemodynamics, and clinical prognosis for hemorrhagic MMD.
Introduction: The Challenge of Hemorrhagic Moyamoya Disease
Moyamoya disease (MMD) is a progressive cerebrovascular disorder characterized by the narrowing of the internal carotid arteries. To compensate, the brain develops fragile, "puff of smoke" collateral vessels. In adults, these vessels are prone to rupture, leading to life-threatening intracranial hemorrhages.
While surgical revascularization is established as the primary treatment to prevent rebleeding, the choice between Indirect Bypass (IB)—which relies on placing vascularized tissue on the brain surface to stimulate natural vessel growth—and Combined Bypass (CB)—which adds a direct artery-to-artery anastomosis—remains a subject of debate. This study addresses this gap by evaluating not just clinical outcomes, but also the underlying physiological changes in blood flow and vessel formation.
Methods and Patient Cohort
The researchers conducted a retrospective cohort study of 37 patients, representing 68 cerebral hemispheres, treated between 2014 and 2019. Patients were categorized into two groups based on the surgical technique:
- Combined Bypass (CB) Group: Received Superficial Temporal Artery to Middle Cerebral Artery (STA-MCA) anastomosis plus Encephalo-duro-arterio-myo-synangiosis (EDAMS).
- Indirect Bypass (IB) Group: Received EDAMS only.
Evaluation involved Digital Subtraction Angiography (DSA) to assess neovascularization using the Matsushima scale, and CT Perfusion (CTP) to measure hemodynamic parameters such as relative cerebral blood flow (rCBF). Functional independence was tracked using the Modified Rankin Scale (mRS).
Key Insights: Direct Flow and Physiological Adaptation
The study's findings suggest that the immediate restoration of blood flow provided by the direct component of a combined bypass acts as a catalyst for long-term physiological improvement. By providing a robust alternative blood supply, CB reduces the hemodynamic "stress" on the fragile, deep moyamoya vessels (AchA/PcoA), which are the primary sources of rebleeding.
Results: Superiority of Combined Bypass
After an average follow-up of 16.5 months, the CB group outperformed the IB group across all primary metrics:
- Clinical Prognosis: The rebleeding rate was significantly lower in the CB group (2.1%) compared to the IB group (19.0%). Furthermore, 97.9% of CB patients achieved favorable functional outcomes (mRS ≤ 2), vs. 76.2% in the IB group.
- Neovascularization: "Satisfactory" vessel growth, defined as Matsushima Grade A or B, was achieved in 87.2% of CB hemispheres compared to only 52.4% in the IB group.
- Hemodynamics: While both procedures improved blood flow, the CB group showed a dramatically higher increase in relative Cerebral Blood Flow (rCBF) (1.65 ± 0.52) compared to the IB group (1.15 ± 0.12), indicating more comprehensive restoration of brain perfusion.
Conclusion and Future Directions
The study concludes that combined bypass revascularization is superior to indirect bypass for treating hemorrhagic MMD, offering better postoperative collateral formation, improved cerebral hemodynamics, and a lower risk of recurrent stroke.
While limited by its retrospective nature and small sample size, the study provides strong evidence for the benefits of direct anastomosis in this patient population. Future research should focus on multi-center prospective trials to confirm these findings and explore the long-term (5-10 year) durability of these surgical benefits.
Summary updated